Treatment Matched to Each Child's Risk for Infants and Young Children With Medulloblastoma
Original title: Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a mid-stage test that is still checking how well this plan works.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study is testing whether treatment planned around each young child's own tumor and health can help.
Who this trial is for. This trial is for infants and young children who were just found to have medulloblastoma, a brain tumor. It is testing a plan that picks each child's treatment based on their tumor's genes and their health.
Where it stands. The trial has not reported results yet. It is still looking at how well this way of planning treatment works for young children. The answer is not in yet.
What this means, and what it doesn't
What it could mean: This trial takes place at many hospitals in more than one country. If your child was just found to have medulloblastoma, you could ask the care team if this trial might fit. The trial team decides who can join.
What it doesn't mean: A trial is a test, not a proven treatment. Being in a trial does not promise that your child will do better. This is not a cure, and it does not mean this plan works yet.
Source: ClinicalTrials.gov, September 15, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.